Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox

NCT00668304 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Maxillary Sinusitis

Interventions

DRUG: Avelox (Moxifloxacin, BAY12-8039)

Sponsor

Bayer